Sign in Pull a receipt

COGT

Cogent Biosciences, Inc.

Biotechnology · Biotechnology

$287.86 sample

-3.76 (-1.29%) 1D

Market cap

$163.0B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-13

Alerts

8

Price$287.86 -1.46% 3M daily closessample

307.39287.05

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27INSInsider sell: Chief Executive Officer
Oct 19INSInsider sell: Chief Financial Officer
Oct 13SEC8-K filed: material event
Oct 08INSInsider sell: EVP, Operations
Sep 29INSInsider sell: Chief Financial Officer
Sep 21INSInsider sell: Director
Sep 15INSInsider sell: EVP, Operations
Sep 10INSInsider sell: 10% owner

Sign up to see the real COGT record →

Company facts

SEC EDGAR registration

Name: Cogent Biosciences, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +41sample, -100 to +100
Reporting currency: USD

Who is positioning in COGT

sample

Insiders: 7 insider transactions over 90 days, net selling, $647.6M
Congress: 1 members traded over 90 days
Institutions · 13F: 7 funds hold $1.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$8.1B +15.8% y/y

Q4 2024Q3 2026

Inventory$4.7B +13.8% y/y

Q4 2024Q3 2026

Accounts receivable$3.7B +13.1% y/y

Q4 2024Q3 2026

Total debt$9.7B +14.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $108.3B -2.0% 3M
Sample peer B: $100.3B -7.6% 3M
Sample peer C: $35.2B -1.8% 3M
Sample peer D: $66.8B -2.2% 3M
Sample peer E: $81.5B -4.3% 3M